Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: 
Relevance to Schizophrenia Pathogenesis and Treatment

Lum, Jeremy S.; Fernandez, Francesca; Matosin, Natalie; Andrews, Jessica L.; Huang, Xu-Feng; Ooi, Lezanne; Newell, Kelly A.

doi:10.1038/srep34391

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment

MPS-Authors

/persons/resource/persons202089

Matosin, Natalie
external;
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

srep34391.pdf
(Any fulltext), 1008KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Lum, J. S., Fernandez, F., Matosin, N., Andrews, J. L., Huang, X.-F., Ooi, L., et al. (2016). Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment. SCIENTIFIC REPORTS, 6: 34391. doi:10.1038/srep34391.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002C-44FF-C

Abstract

Group 1 metabotropic glutamate receptors (mGluR1/mGluR5) play an integral role in neurodevelopment and are implicated in psychiatric disorders, such as schizophrenia. mGluR1 and mGluR5 are expressed as homodimers, which is important for their functionality and pharmacology. We examined the protein expression of dimeric and monomeric mGluR1 alpha and mGluR5 in the prefrontal cortex (PFC) and hippocampus throughout development (juvenile/adolescence/adulthood) and in the perinatal phencyclidine (PCP) model of schizophrenia. Under control conditions, mGluR1a dimer expression increased between juvenile and adolescence (209-328%), while monomeric levels remained consistent. Dimeric mGluR5 was steadily expressed across all time points; monomeric mGluR5 was present in juveniles, dramatically declining at adolescence and adulthood (-97-99%). The mGluR regulators, Homer 1b/c and Norbin, significantly increased with age in the PFC and hippocampus. Perinatal PCP treatment significantly increased juvenile dimeric mGluR5 levels in the PFC and hippocampus (37-50%) but decreased hippocampal mGluR1a (-50-56%). Perinatal PCP treatment also reduced mGluR1a dimer levels in the PFC at adulthood (-31%). These results suggest that Group 1 mGluRs have distinct dimeric and monomeric neurodevelopmental patterns, which may impact their pharmacological profiles at specific ages. Perinatal PCP treatment disrupted the early expression of Group 1 mGluRs which may underlie neurodevelopmental alterations observed in this model.